VOREND voriconazole 200mg tablet blister pack

Država: Australija

Jezik: engleski

Izvor: Department of Health (Therapeutic Goods Administration)

Aktivni sastojci:

voriconazole, Quantity: 200 mg

Dostupno od:

Medis Pharma Pty Ltd

INN (International ime):

Voriconazole

Farmaceutski oblik:

Tablet, film coated

Sastav:

Excipient Ingredients: croscarmellose sodium; povidone; microcrystalline cellulose; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; triacetin; macrogol 3350

Administracija rute:

Oral

Jedinice u paketu:

28, 10, 56, 2, 14, 100, 50, 30, 20

Tip recepta:

(S4) Prescription Only Medicine

Terapijske indikacije:

Vorend is indicated for treatment of the following fungal infections:,Invasive aspergillosis.,Serious Candida infections (including C. krusei), including oesophageal and systemic Candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,Serious fungal infections caused by Scedosporium spp and Fusarium spp.,Other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,Prophylaxis in patients who are at high risk of developing invasive fungal infections. The indication is based on studies including patients undergoing haematopoietic stem cell transplantation. This brand is only available as tablets and therefore only indicated for adults and children 12 years or older who can tolerate tablets.

Proizvod sažetak:

Visual Identification: white, oval biconvex tablets, debossed 'VC200' on one side and plain on the reverse; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Status autorizacije:

Licence status A

Datum autorizacije:

2015-02-02